Literature DB >> 6153938

Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid.

M F Braña, J M Castellano, C M Roldán, A Santos, D Vázquez, A Jiménez.   

Abstract

Four new imide derivatives of 3-nitro-1,8-naphthalic acid have been synthesised. The compounds show strong cytostatic activity against both HeLa and KB cells and are moderately toxic towards both mice and rats (LD50 above 4 mg/kg IP). Two of the most active compounds, M-4212 and M-12210, prevented the development of mouse Ehrlich ascites and rat Yoshida carcinoma. All these drugs block cell growth by inhibiting the synthesis of both DNA and RNA. In particular, both M-4212 and M-12210 raise the melting point of double-stranded DNA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153938     DOI: 10.1007/BF00255461

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

1.  TUMOR INHIBITORS. I. ARISTOLOCHIC ACID, THE ACTIVE PRINCIPLE OF ARISTOLOCHIA INDICA.

Authors:  S M KUPCHAN; R W DOSKOTCH
Journal:  J Med Pharm Chem       Date:  1962-05

2.  Inhibitors of protein synthesis in eukarytic cells. Comparative effects of some amaryllidaceae alkaloids.

Authors:  A Jimenez; A Santos; G Alonso; D Vazquez
Journal:  Biochim Biophys Acta       Date:  1976-03-17

3.  Influence of tilorone and cogeners on the secondary structure and template activity of DNA.

Authors:  P Chandra; M Woltersdorf
Journal:  FEBS Lett       Date:  1974-04-15       Impact factor: 4.124

Review 4.  Inhibitors of protein synthesis.

Authors:  D Vazquez
Journal:  FEBS Lett       Date:  1974-03-23       Impact factor: 4.124

5.  Experimental therapeutic investigations with 1-(morpholinomethyl)-4-phthalimido-piperidindione-2,6 on dimethylbenzanthracene-induced tumors of Sprague-Dawley rats.

Authors:  H Mückter; E Frankus; E Moré
Journal:  Cancer Res       Date:  1969-06       Impact factor: 12.701

  5 in total
  28 in total

1.  Synthesis and photophysical characterizations of thermal-stable naphthalene benzimidazoles.

Authors:  Sule Erten-Ela; Serdar Ozcelik; Esin Eren
Journal:  J Fluoresc       Date:  2011-01-29       Impact factor: 2.217

2.  Computer simulation of the binding of amonafide and azonafide to DNA.

Authors:  S Bear; W A Remers
Journal:  J Comput Aided Mol Des       Date:  1996-04       Impact factor: 3.686

3.  Synthesis and Photophysical Studies on Naphthalimide Derived Fluorophores as Markers in Drug Delivery.

Authors:  Nidhi Singh; Ritika Srivastava; Anuradha Singh; Ramendra K Singh
Journal:  J Fluoresc       Date:  2016-05-26       Impact factor: 2.217

4.  Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.

Authors:  Sebastian Rykowski; Dorota Gurda-Woźna; Marta Orlicka-Płocka; Agnieszka Fedoruk-Wyszomirska; Małgorzata Giel-Pietraszuk; Eliza Wyszko; Aleksandra Kowalczyk; Paweł Stączek; Andrzej Bak; Agnieszka Kiliszek; Wojciech Rypniewski; Agnieszka B Olejniczak
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

5.  Effects of benzoylphenyl ureas on growth of B16 melanoma cells in vitro and in vivo.

Authors:  H P Hofs; J G McVie
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

6.  Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses.

Authors:  A Garcá Gancedo; C Gil-Fernández; P Vilas; S Perez; E Paez; F Rodriguez; M F Braña; C M Roldán
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer.

Authors:  R Rosell; J Carles; A Abad; N Ribelles; A Barnadas; A Benavides; M Martin
Journal:  Invest New Drugs       Date:  1992-08       Impact factor: 3.850

8.  Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi.

Authors:  K M Slunt; J M Grace; T L Macdonald; R D Pearson
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  In vitro activity of amonafide against primary human tumors compared with the activity of standard agents.

Authors:  J A Ajani; F L Baker; G Spitzer
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

10.  Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.

Authors:  C S Higano; P Goodman; J B Craig; J A Kish; S E Rivkin; M Wolf; E D Crawford
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.